These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 25054634

  • 21. Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database.
    Kunz D, Bineau S, Maman K, Milea D, Toumi M.
    Expert Opin Pharmacother; 2012 Jan; 13(1):9-16. PubMed ID: 22107732
    [Abstract] [Full Text] [Related]

  • 22. Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries.
    Clay E, Falissard B, Moore N, Toumi M.
    Eur J Clin Pharmacol; 2013 Apr; 69(4):1-10. PubMed ID: 23114457
    [Abstract] [Full Text] [Related]

  • 23. Insomnia: Pharmacologic Treatment.
    Lou BX, Oks M.
    Clin Geriatr Med; 2021 Aug; 37(3):401-415. PubMed ID: 34210446
    [Abstract] [Full Text] [Related]

  • 24. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R, Rüther E, Farr I, Emilien G, Salinas E.
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [Abstract] [Full Text] [Related]

  • 25. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial.
    Ivgy-May N, Roth T, Ruwe F, Walsh J.
    Sleep Med; 2015 Jul; 16(7):831-7. PubMed ID: 26047890
    [Abstract] [Full Text] [Related]

  • 26. [Melatonin--a natural hypnotic?].
    Saletu B.
    Wien Klin Wochenschr; 1997 Oct 03; 109(18):714-21. PubMed ID: 9441514
    [Abstract] [Full Text] [Related]

  • 27. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.
    Morin CM, Koetter U, Bastien C, Ware JC, Wooten V.
    Sleep; 2005 Nov 03; 28(11):1465-71. PubMed ID: 16335333
    [Abstract] [Full Text] [Related]

  • 28. [Therapeutic approaches for sleep and rhythms disorders in children with ASD].
    Schröder CM, Broquère MA, Claustrat B, Delorme R, Franco P, Lecendreux M, Tordjman S.
    Encephale; 2022 Jun 03; 48(3):294-303. PubMed ID: 35120753
    [Abstract] [Full Text] [Related]

  • 29. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
    Lähteenmäki R, Neuvonen PJ, Puustinen J, Vahlberg T, Partinen M, Räihä I, Kivelä SL.
    Basic Clin Pharmacol Toxicol; 2019 Mar 03; 124(3):330-340. PubMed ID: 30295409
    [Abstract] [Full Text] [Related]

  • 30. Improvement of sleep quality in elderly people by controlled-release melatonin.
    Garfinkel D, Laudon M, Nof D, Zisapel N.
    Lancet; 1995 Aug 26; 346(8974):541-4. PubMed ID: 7658780
    [Abstract] [Full Text] [Related]

  • 31. Sleep complaints: Whenever possible, avoid the use of sleeping pills.
    Prescrire Int; 2008 Oct 26; 17(97):206-12. PubMed ID: 19536941
    [Abstract] [Full Text] [Related]

  • 32. Postmarketing surveillance of zopiclone in insomnia: analysis of 20,513 cases.
    Allain H, Delahaye C, Le Coz F, Blin P, Decombe R, Martinet JP.
    Sleep; 1991 Oct 26; 14(5):408-13. PubMed ID: 1759093
    [Abstract] [Full Text] [Related]

  • 33. Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial.
    Roth T, Nir T, Zisapel N.
    Nat Sci Sleep; 2015 Oct 26; 7():13-23. PubMed ID: 25678831
    [Abstract] [Full Text] [Related]

  • 34. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun 26; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 35. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group.
    Sleep; 2008 Jan 26; 31(1):79-90. PubMed ID: 18220081
    [Abstract] [Full Text] [Related]

  • 36. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L.
    Neuropsychobiology; 1997 Jan 26; 36(3):130-52. PubMed ID: 9313245
    [Abstract] [Full Text] [Related]

  • 37. Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases.
    Hajak G, Bandelow B.
    Int Clin Psychopharmacol; 1998 Jul 26; 13(4):157-67. PubMed ID: 9727726
    [Abstract] [Full Text] [Related]

  • 38. Effects of pregabalin in patients with hypnotic-dependent insomnia.
    Cho YW, Song ML.
    J Clin Sleep Med; 2014 May 15; 10(5):545-50. PubMed ID: 24812540
    [Abstract] [Full Text] [Related]

  • 39. Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study.
    Andrade C, Srihari BS, Reddy KP, Chandramma L.
    J Clin Psychiatry; 2001 Jan 15; 62(1):41-5. PubMed ID: 11235927
    [Abstract] [Full Text] [Related]

  • 40. Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia.
    Uchiyama M, Hamamura M, Kuwano T, Nagata H, Hashimoto T, Ogawa A, Uchimura N.
    Sleep Med; 2011 Feb 15; 12(2):127-33. PubMed ID: 21277255
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.